UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Functional expression of sodium-glucose transporters in cancer

Proceedings of the National Academy of Sciences - PNAS, 2015-07, Vol.112 (30), p.E4111-E4119

2015

Volltextzugriff (PDF)

Memory and Brain Amyloid and Tau Effects of a Bioavailable Form of Curcumin in Non-Demented Adults: A Double-Blind, Placebo-Controlled 18-Month Trial

The American journal of geriatric psychiatry, 2018-03, Vol.26 (3), p.266-277

2018

Volltextzugriff (PDF)

Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer's Disease: The Role of APP

Journal of Alzheimer's disease, 2017-01, Vol.56 (2), p.459-470

2017

Volltextzugriff (PDF)

Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma

Science translational medicine, 2018-11, Vol.10 (467)

2018

Volltextzugriff (PDF)

In vivo characterization of chronic traumatic encephalopathy using [F-18]FDDNP PET brain imaging

Proceedings of the National Academy of Sciences - PNAS, 2015-04, Vol.112 (16), p.E2039-E2047

2015

Volltextzugriff (PDF)

PET Scanning of Brain Tau in Retired National Football League Players: Preliminary Findings

The American journal of geriatric psychiatry, 2013-02, Vol.21 (2), p.138-144

2013

Volltextzugriff (PDF)

Towards a pharmacophore for amyloid

PLoS biology, 2011-06, Vol.9 (6), p.e1001080

2011

Volltextzugriff (PDF)

Revisiting the physiological roles of SGLTs and GLUTs using positron emission tomography in mice

The Journal of physiology, 2016-08, Vol.594 (15), p.4425-4438

2016

Volltextzugriff (PDF)

Dapagliflozin Binds Specifically to Sodium-Glucose Cotransporter 2 in the Proximal Renal Tubule

Journal of the American Society of Nephrology, 2017-03, Vol.28 (3), p.802-810

2017

Volltextzugriff (PDF)

Alzheimer's Amyloid Hypothesis and Antibody Therapy: Melting Glaciers?

International journal of molecular sciences, 2024-04, Vol.25 (7), p.3892

2024

Volltextzugriff (PDF)

Regional distribution of SGLT activity in rat brain in vivo

American Journal of Physiology: Cell Physiology, 2013-02, Vol.304 (3), p.C240-C247

2013

Volltextzugriff (PDF)

PET of Brain Amyloid and Tau in Mild Cognitive Impairment

The New England journal of medicine, 2006-12, Vol.355 (25), p.2652-2663

2006

Volltextzugriff (PDF)

Positron emission tomography of sodium glucose cotransport activity in high grade astrocytomas

Journal of neuro-oncology, 2018-07, Vol.138 (3), p.557-569

2018

Volltextzugriff (PDF)

Longer TOMM40 poly-T variants associated with higher FDDNP-PET medial temporal tau and amyloid binding

PloS one, 2018-12, Vol.13 (12), p.e0208358

2018

Volltextzugriff (PDF)

Modifiable Risk Factors and Brain Positron Emission Tomography Measures of Amyloid and Tau in Nondemented Adults with Memory Complaints

The American journal of geriatric psychiatry, 2016-09, Vol.24 (9), p.729-737

2016

Volltextzugriff (PDF)

Functional expression of SGLTs in rat brain

American Journal of Physiology: Cell Physiology, 2010-12, Vol.299 (6), p.C1277-C1284

2010

Volltextzugriff (PDF)

PET imaging of neuropathology in tauopathies: progressive supranuclear palsy

Journal of Alzheimer's disease, 2013-01, Vol.36 (1), p.145-153

2013

Volltextzugriff (PDF)

Structural selectivity of human SGLT inhibitors

American Journal of Physiology: Cell Physiology, 2012-01, Vol.302 (2), p.C373-C382

2012

Volltextzugriff (PDF)

Design, Syntheses, and in Vitro Evaluation of New Fluorine-18 Radiolabeled Tau-Labeling Molecular Probes

Journal of medicinal chemistry, 2017-11, Vol.60 (21), p.8741-8757

2017

Volltextzugriff (PDF)

The Irony of PET Tau Probe Specificity

Journal of Nuclear Medicine, 2018-01, Vol.59 (1), p.115-116

Barrio, Jorge R

2018

Volltextzugriff (PDF)

Current and future uses of neuroimaging for cognitively impaired patients

Lancet neurology, 2008-02, Vol.7 (2), p.161-172

2008

Volltextzugriff (PDF)

Serotonin 1A Receptors in the Living Brain of Alzheimer's Disease Patients

Proceedings of the National Academy of Sciences - PNAS, 2006-01, Vol.103 (3), p.702-707

2006

Volltextzugriff (PDF)

FDG-PET versus Amyloid-PET Imaging for Diagnosis and Response Evaluation in Alzheimer's Disease: Benefits and Pitfalls

Diagnostics (Basel), 2023-07, Vol.13 (13), p.2254

2023

Volltextzugriff (PDF)

Progressive Focal Gray Matter Volume Loss in a Former High School Football Player: A Possible Magnetic Resonance Imaging Volumetric Signature for Chronic Traumatic Encephalopathy

The American journal of geriatric psychiatry, 2016-10, Vol.24 (10), p.784-790

2016

Volltextzugriff (PDF)

The merits of FDDNP-PET imaging in Alzheimer's disease

Journal of Alzheimer's disease, 2011-01, Vol.26 Suppl 3 (s3), p.135-145

2011

Volltextzugriff (PDF)

1 – 25 von 384

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(347)
Mit Volltextzugriff
(322)

Publikationsform

Sprache

Englisch
(380)
Spanisch
(3)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(232)
Life Sciences & Biomedicine
(181)
Humans
(131)
Male
(81)
Animals
(72)
Biological And Medical Sciences
(65)
Female
(63)
Positron Emission Tomography
(55)
Chemistry
(53)
Neurosciences & Neurology
(50)
Middle Aged
(47)
Radiology, Nuclear Medicine & Medical Imaging
(47)
Physical Sciences
(46)
Aged
(45)
Medical Sciences
(45)
Neurosciences
(45)
Alzheimer's Disease
(44)
Fluorine Radioisotopes
(44)
Positron-Emission Tomography
(43)
Brain - Metabolism
(42)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Functional expression of sodium-glucose transporters in cancer

Memory and Brain Amyloid and Tau Effects of a Bioavailable Form of Curcumin in Non-Demented Adults: A Double-Blind, Placebo-Controlled 18-Month Trial

Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer's Disease: The Role of APP

Sodium-glucose transporter 2 is a diagnostic and therapeutic target for early-stage lung adenocarcinoma

In vivo characterization of chronic traumatic encephalopathy using [F-18]FDDNP PET brain imaging

PET Scanning of Brain Tau in Retired National Football League Players: Preliminary Findings

Towards a pharmacophore for amyloid

Revisiting the physiological roles of SGLTs and GLUTs using positron emission tomography in mice

Dapagliflozin Binds Specifically to Sodium-Glucose Cotransporter 2 in the Proximal Renal Tubule

Alzheimer's Amyloid Hypothesis and Antibody Therapy: Melting Glaciers?

Regional distribution of SGLT activity in rat brain in vivo

PET of Brain Amyloid and Tau in Mild Cognitive Impairment

Positron emission tomography of sodium glucose cotransport activity in high grade astrocytomas

Longer TOMM40 poly-T variants associated with higher FDDNP-PET medial temporal tau and amyloid binding

Modifiable Risk Factors and Brain Positron Emission Tomography Measures of Amyloid and Tau in Nondemented Adults with Memory Complaints

Functional expression of SGLTs in rat brain

PET imaging of neuropathology in tauopathies: progressive supranuclear palsy

Structural selectivity of human SGLT inhibitors

Design, Syntheses, and in Vitro Evaluation of New Fluorine-18 Radiolabeled Tau-Labeling Molecular Probes

The Irony of PET Tau Probe Specificity

Current and future uses of neuroimaging for cognitively impaired patients

Serotonin 1A Receptors in the Living Brain of Alzheimer's Disease Patients

FDG-PET versus Amyloid-PET Imaging for Diagnosis and Response Evaluation in Alzheimer's Disease: Benefits and Pitfalls

Progressive Focal Gray Matter Volume Loss in a Former High School Football Player: A Possible Magnetic Resonance Imaging Volumetric Signature for Chronic Traumatic Encephalopathy

The merits of FDDNP-PET imaging in Alzheimer's disease

Suchergebnisse filtern